Pharmacologically triggered hydrogel for scheduling hepatitis B vaccine administration

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Gübeli, Raphael J ^a   Schöneweis, Katrin ^b   Huzly, Daniela ^c   Ehrbar, Martin ^d   Charpin El Hamri, Ghislaine ^e   El Baba, Marie Daoud ^e   Urban, Stephan ^b   Weber, Wilfried ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCOUMARIN DERIVATIVE; COUMAMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING); HEPATITIS B VACCINE; MACROGOL DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; DELAYED RELEASE FORMULATION; FEMALE; HEPATITIS B; HYDROGEL; IMMUNOLOGY; MOUSE; VACCINATION;

AMINOCOUMARINS; ANIMALS; DELAYED-ACTION PREPARATIONS; DNA GYRASE; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HYDROGELS; MICE; POLYETHYLENE GLYCOLS; VACCINATION;

EID: 84902926147     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02610     Document Type: Article

References (31)

1. Arita, I. Virological Evidence for the Success of the Smallpox Eradication Program. Nature 279, 293-298 (1979).
2. Hull, H. F. Pax Polio. Science 275, 40-41 (1997).
3. Nossal, G. J. V. The Global Alliance for Vaccines and Immunization - a millennial challenge. Nat Immunol 1, 5-8 (2000).
4. Nossal, G. J. Global immunization for the 21st century. Science 284, 587 (1999).
5. Anand, S. & Barnighausen, T. Health workers and vaccination coverage in developing countries: an econometric analysis. Lancet 369, 1277-1285 (2007).
6. Daar, A. S. et al. Top ten biotechnologies for improving health in developing countries. Nat Genet 32, 229-232 (2002).
7. Goldstein, S. T. et al. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34, 1329-1339 (2005).
8. Goldstein, S. Global Routine Vaccination Coverage, 2010 (Reprinted from MMWR, vol 60, pg 1520-1522, 2011). Jama-J Am Med Assoc 306, 2662-2664 (2011).
9. Mohammed, J. S. & Murphy, W. L. Bioinspired Design of Dynamic Materials. Adv. Mater. 21, 2361-2374 (2009).
10. Ehrbar, M., Schoenmakers, R., Christen, E. H., Fussenegger, M. & Weber, W. Drug-sensing hydrogels for the inducible release of biopharmaceuticals. Nat Mater 7, 800-804 (2008).
11. Kampf, M. M. et al. A Gene Therapy Technology-Based Biomaterial for the Trigger-Inducible Release of Biopharmaceuticals in Mice. Adv Funct Mater 20, 2534-2538 (2010).
12. Christen, E. H. et al. Conditional DNA-Protein Interactions Confer Stimulus-Sensing Properties to Biohybrid Materials. Adv Funct Mater 21, 2861-2867 (2011).
13. Geraths, C., Daoud-El Baba, M., Charpin-El Hamri, G. &Weber, W. A biohybrid hydrogel for the urate-responsive release of urate oxidase. J. Control. Release (2013).
14. Jakobus, K., Wend, S. & Weber, W. Synthetic mammalian gene networks as a blueprint for the design of interactive biohybrid materials. Chemical Society reviews 41, 1000-1018 (2012).
15. Gubeli, R. J., Ehrbar, M., Fussenegger, M., Friedrich, C. & Weber, W. Synthesis and Characterization of PEG-Based Drug-Responsive Biohybrid Hydrogels. Macromolecular rapid communications 33, 1280-1285 (2012).
16. Andre, F. E. & Safary, A. Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine. Postgraduate medical journal 63 Suppl 2, 169-177 (1987).
17. Bachmann, M. F. & Jennings, G. T. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 10, 787-796 (2010).
18. Miller, A. K., Verwey, W. F. & West, M. K. A laboratory evaluation of the chemotherapeutic properties of cathomycin. Antibiotics annual 3, 924-928 (1955).
19. Solotorovsky, M., Valiant, M. E., Frost, B. M. & Cuckler, A. C. Further studies on microbiological activity of novobiocin. Antibiot and Chemother 8, 86-92 (1958).
20. Hahm, H. A. et al. Novobiocin in combination with high-dose chemotherapy for the treatment of advanced breast cancer: a phase 2 study. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation 6, 335-343 (2000).
21. Eder, J. P., Wheeler, C. A., Teicher, B. A. & Schnipper, L. E. A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity. Cancer research 51, 510-513 (1991).
22. Jalota, S., Bhaduri, S. B. & Tas, A. C. Using a synthetic body-fluid (SBF) solution of 27 mM HCO3-to make bone substitutes more osteointegrative. Mat Sci Eng CBio S 28, 129-140 (2008).
23. Schulze, A., Schieck, A., Ni, Y., Mier, W. & Urban, S. Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor Interaction. J Virol 84, 1989-2000 (2010).
24. Deepen, R.,Heermann, K. H.,Uy, A., Thomssen, R.&Gerlich,W.H.Assay of Pres Epitopes and Pres1 Antibody in Hepatitis-B Virus Carriers and Immune Persons. Med Microbiol Immun 179, 49-60 (1990).
25. Glebe, D. et al. Pre-S1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Virol 77, 9511-9521 (2003).
26. Ali, O. A.,Huebsch, N., Cao, L., Dranoff, G. & Mooney, D. J. Infection-mimicking materials to program dendritic cells in situ. Nat Mater 8, 151-158 (2009).
27. Singh, A., Suri, S. & Roy, K. In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells. Biomaterials 30, 5187-5200 (2009).
28. Farra, R. et al. First-in-Human Testing of aWirelessly Controlled Drug Delivery Microchip. Science Translational Medicine 4 (2012).
29. Weber, C. C. et al. Broad-spectrum protein biosensors for class-specific detection of antibiotics. Biotechnology and bioengineering 89, 9-17 (2005).
30. Gripon, P. et al. Infection of a human hepatoma cell line by hepatitis B virus. PNatl Acad Sci USA 99, 15655-15660 (2002).
31. Ladner, S. K. et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: A novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Ch 41, 1715-1720 (1997).